Cardiovascular Disease Doctors in Hickory, NC Accepting Medicare

8 Cardiovascular Disease doctors found. Showing 1 - 8

Dr. Philip Alexander Paspa, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2660 Tate Blvd Se, Hickory, NC 28602 Phone: 828-261-0009    Fax: 828-261-0799

Dr. James M Ritter, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 524 6th St Nw, Hickory, NC 28601 Phone: 302-740-4828

Dr. Pairoj Rerkpattanapipat, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2660 Tate Blvd Se, Hickory, NC 28602 Phone: 828-261-0009    Fax: 828-261-0799

Dr. Sanjay Kumar Patel, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1771 Tate Blvd Se, Suite 201, Hickory, NC 28602 Phone: 828-324-4804    Fax: 828-324-7256

Dr. Brian Paul Hearon, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1771 Tate Blvd Se, Suite 201, Hickory, NC 28602 Phone: 828-324-4804    Fax: 828-324-7256

Dr. Ghassan Soultan Alkoutami, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2660 Tate Blvd Se, Hickory, NC 28602 Phone: 828-216-0009    Fax: 828-261-0109

Dr. Ralph Norman Mc Donald, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1771 Tate Blvd Se, Suite 201, Hickory, NC 28602 Phone: 828-324-4804    Fax: 828-324-7256

Justin Hicks, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 810 Fairgrove Church Rd, Hickory, NC 28602 Phone: 828-326-3000

News Archive

Immunocompromised patients using rituximab could benefit from third COVID-19 booster vaccine

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows immunocompromised patients using rituximab (a drug used to treat diseases like rheumatoid arthritis) were able to produce antibodies against COVID-19 (seroconvert) after receiving a third COVID-19 vaccine dose, even if there was no development of the antibody after the first two doses of the vaccine.

Debiopharm signs new license and research agreement with Yale University

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, announced it has signed a new license and research agreement with Yale University (Yale), a premier university with a long tradition of basic and clinical biomedical research, regarding the discovery of MIF inhibitors for treatment of autoimmune and inflammatory diseases.

Pre-clinical study results of EVP-0015962 presented at AAICAD 2010

EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.

Some doctors refuse to see Obamacare enrollees

Subscribers are running into closed doors from some doctors listed in their plans' networks, reports The Miami Herald. Meanwhile, Connecticut advocates express concern about how a proposed overhaul of the state's health care system could change Medicaid, and in Washington state, providers scramble to keep up with demand.

Methods using preventive analgesia to treat pain after surgery before it develops

York University Professor Joel Katz is studying methods of preventing or significantly reducing pain after surgery by employing preemptive or preventive analgesia to treat pain before it develops.

Read more Medical News

› Verified 8 days ago